Better than CAR-T? Already prepping for a US launch, MorphoSys posts stellar DLBCL data to...


cafead

Administrator
Staff member
  • cafead   May 17, 2019 at 01:12: PM
via Already beavering away at building a US commercial operation, MorphoSys {$MOR} is now bearing down on Novartis and Gilead with a potential CAR-T killer soon to be put into the hands of US regulators.

article source
 


Write your reply...